chr2-165748461-C-CTA
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_004482.4(GALNT3):c.*319_*320insTA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000452 in 343,188 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00054 ( 0 hom. )
Consequence
GALNT3
NM_004482.4 3_prime_UTR
NM_004482.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.300
Genes affected
GALNT3 (HGNC:4125): (polypeptide N-acetylgalactosaminyltransferase 3) This gene encodes UDP-GalNAc transferase 3, a member of the GalNAc-transferases family. This family transfers an N-acetyl galactosamine to the hydroxyl group of a serine or threonine residue in the first step of O-linked oligosaccharide biosynthesis. Individual GalNAc-transferases have distinct activities and initiation of O-glycosylation is regulated by a repertoire of GalNAc-transferases. The protein encoded by this gene is highly homologous to other family members, however the enzymes have different substrate specificities. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.000537 (103/191914) while in subpopulation MID AF= 0.00346 (3/868). AF 95% confidence interval is 0.000942. There are 0 homozygotes in gnomad4_exome. There are 59 alleles in male gnomad4_exome subpopulation. Median coverage is 0. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GALNT3 | NM_004482.4 | c.*319_*320insTA | 3_prime_UTR_variant | 11/11 | ENST00000392701.8 | ||
GALNT3 | XM_005246449.2 | c.*319_*320insTA | 3_prime_UTR_variant | 11/11 | |||
GALNT3 | XM_011510929.2 | c.*319_*320insTA | 3_prime_UTR_variant | 11/11 | |||
GALNT3 | XM_017003770.2 | c.*319_*320insTA | 3_prime_UTR_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GALNT3 | ENST00000392701.8 | c.*319_*320insTA | 3_prime_UTR_variant | 11/11 | 1 | NM_004482.4 | P1 | ||
GALNT3 | ENST00000409882.5 | c.*319_*320insTA | 3_prime_UTR_variant | 8/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000351 AC: 53AN: 151164Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
53
AN:
151164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000537 AC: 103AN: 191914Hom.: 0 Cov.: 0 AF XY: 0.000607 AC XY: 59AN XY: 97272
GnomAD4 exome
AF:
AC:
103
AN:
191914
Hom.:
Cov.:
0
AF XY:
AC XY:
59
AN XY:
97272
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000344 AC: 52AN: 151274Hom.: 0 Cov.: 32 AF XY: 0.000298 AC XY: 22AN XY: 73882
GnomAD4 genome
AF:
AC:
52
AN:
151274
Hom.:
Cov.:
32
AF XY:
AC XY:
22
AN XY:
73882
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at